Allarity Therapeutics Inc. share price logo

Allarity Therapeutics Inc.

NASDAQ: ALLR

$1.30

-0.03

(-2.36%)

as on

Allarity Therapeutics Inc. Stock Performance

as on July 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.28
    $1.38
    downward going graph

    1.54%

    Downside

    6.15%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.77
    $2.35
    downward going graph

    40.87%

    Downside

    80.77%

    Upside

    downward going graph

Allarity Therapeutics Inc. share price movements today

Previous Close
$1.33
Open
$1.35
Volume
281.8K
Day's Low - High
$1.28 - $1.38
52 Week Low - High
$0.77 - $2.35

Allarity Therapeutics Inc. Historical Returns

1 Month Return
-21.3 %
3 Month Return
+ 14.66 %
1 Year Return
+ 33 %
3 Year Return
-99.97 %
5 Year Return
0 %

Allarity Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Allarity Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.2M

EPS (TTM)

-0.92

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-12.6M

Revenue (TTM)

345.0K

Profit Margin

0.00%

Return On Equity TTM

-87.92%

Allarity Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Allarity Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Allarity Therapeutics Inc. image
Allarity Therapeutics Inc.
SELL$21.2MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.8B472.9%NA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$40.2B75.97%75.8312.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$126.1B148.33%29.535.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B7.04%15.2229.65%0.5700000000000001%

Stock Returns calculator for Allarity Therapeutics Inc. Stock including INR - Dollar returns

The Allarity Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Allarity Therapeutics Inc. investment value today

Current value as on today

₹1,44,826

Returns

₹44,826

(+44.83%)

Returns from Allarity Therapeutics Inc. Stock

₹30,000 (+30%)

Dollar Impact

₹14,826 (+14.83%)

Analyst Recommendation on Allarity Therapeutics Inc. Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Allarity Therapeutics Inc.. Average target price of $10.25

Allarity Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Allarity Therapeutics Inc..

What analysts predicted

87.32%UPSIDE

Target Price

$10.25

Current Price

$1.3

Analyzed by

6 Analysts

Target

$10.25

Allarity Therapeutics Inc. target price $10.25, a slight upside of 87.32% compared to current price of $1.3. According to 6 analysts rating.

Indian Investors' Interest in Allarity Therapeutics Inc. Stock

Search interest for Allarity Therapeutics Inc. Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Allarity Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
-
-
0
-
-
-
0
0
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-4
-4
-3
-12
-7
-3
-4
-2
-2
-2
EBITDA
-4
-3
-1
-11
-7
-2
-2
-2
-3
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-3
-1
-11
-7
-2
-2
-2
-3
-2
Income Tax Expense
0
0
-
0
-
-
-
-
-
-
Net Income
-1
-3
-1
-11
-7
-2
-2
-2
-3
-2
Net Profit Margin
-1537.50%
-3431.25%
0.00%
0.00%
-124216.67%
0.00%
0.00%
0.00%
-1054.06%
-11000.00%

Allarity Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
1
1
0
-
-
-
-
-
0
Gross Profit
0
0
-3
0
0
0
0
0
0
0
Operating Income
-4
-3
-4
-17
-8
-26
-34
-17
-27
-12
EBITDA
-4
-3
-4
-15
-6
-25
-17
-11
-24
-11
Interest Expense
0
0
0
3
0
0
0
0
0
0
Depreciation
-
-
-
0
0
0
0
0
0
0
Income Before Tax
-4
-4
-3
-18
-6
-26
-17
-11
-24
-11
Income Tax Expense
0
0
-1
-4
0
0
-1
0
0
-
Net Income
-3
-4
-2
-14
-6
-26
-16
-11
-24
-11
Net Profit Margin
-2570.36%
-335.69%
-156.97%
-11927.50%
0.00%
0.00%
0.00%
0.00%
0.00%
-3509.69%

Allarity Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-3
-1
-11
-7
-2
-2
-2
-3
-2
Operating Cash Flow
-1
-7
-5
-3
-2
-5
-3
-3
-4
Investing Cash Flow
0
-
-
0
-
-
-
0
0
Financing Cash Flow
1
26
4
4
11
-2
2
0
19
Change in Cash
0
18
0
1
8
-9
0
-2
15

Allarity Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-2
-14
-5
-26
-16
-11
-24
-11
Operating Cash Flow
-1
-4
-10
-7
-15
-16
-12
-17
-14
Investing Cash Flow
0
1
0
0
1
0
-
0
0
Financing Cash Flow
1
2
11
6
33
-1
10
36
10
Change in Cash
-1
0
1
-1
19
-17
-1
19
-4

Global Institutional Holdings in Allarity Therapeutics Inc.

Funds
Holdings
HRT FINANCIAL LLC
0%
Renaissance Technologies Corp
1.43%
Danske Bank A/S.
0%
Goldman Sachs Group Inc
0%
UBS Group AG
0.15%
See all

Allarity Therapeutics Inc. News & Key Events

  • img

    Today's Timeline - 27 April

    Mon, 05:32 PM

    -

    Allarity Therapeutics announces Notice of Allowance for stenoparib DRP® test patent from the US Patent and Trademark Office.

Insights on Allarity Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 601.0% return, outperforming this stock by 701.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 404.2% return, outperforming this stock by 371.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ALLR stock has moved down by -100.0%

About Allarity Therapeutics Inc.

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
OrganisationAllarity Therapeutics Inc.
Headquarters123 E. Tarpon Ave., Tarpon Springs, FL, United States, 34689
IndustryBiotechnology
CEOMr. Thomas H. Jensen
E-voting on sharesClick here to vote

Key Management of Allarity Therapeutics Inc.

Name

Title

Dr. Jose L. Iglesias M.D.

Consultant Chief Medical Officer

Mr. Thomas H. Jensen

Founder, CEO & Director

Dr. Jeremy R. Graff Ph.D.

President & Chief Development Officer

Dr. Steen Meier Knudsen Ph.D.

Founder & Chief Scientific Officer

Mr. Jeffrey S. Ervin M.B.A.

Chief Financial Officer

FAQs

What is Allarity Therapeutics Inc. share price today?

Allarity Therapeutics Inc. share price today is $1.30 as on at the close of the market. Allarity Therapeutics Inc. share today touched a day high of $1.38 and a low of $1.28.

What is the 52 week high and 52 week low for Allarity Therapeutics Inc. share?

Allarity Therapeutics Inc. share touched a 52 week high of $2.35 on and a 52 week low of $0.77 on . Allarity Therapeutics Inc. stock price today i.e. is closed at $1.30,which is 44.68% down from its 52 week high and 69.12% up from its 52 week low.

What is Allarity Therapeutics Inc.'s market capitalisation today?

Allarity Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Allarity Therapeutics Inc. Stock (ALLR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Allarity Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Allarity Therapeutics Inc. Shares that will get you 1.1538 shares as per Allarity Therapeutics Inc. share price of $1.30 per share as on July 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Allarity Therapeutics Inc. Stock (ALLR) from India?

Indian investors can start investing in Allarity Therapeutics Inc. (ALLR) shares with as little as ₹95.39 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in Allarity Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Allarity Therapeutics Inc. share’s latest price of $1.30 as on July 3, 2026 at 1:29 am IST, you will get 7.6923 shares of Allarity Therapeutics Inc.. Learn more about fractional shares .